Article Information
PubMed
Print ISSN
Online ISSN
History
- Received February 16, 2011
- Accepted May 12, 2011
- Published online July 18, 2011.
Article Versions
- Earlier version (May 12, 2011 - 07:58).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Maria L. H. Vlaming1,
- Anita van Esch,
- Evita van de Steeg1,
- Zeliha Pala,
- Els Wagenaar,
- Olaf van Tellingen and
- Alfred H. Schinkel
- Divisions of Molecular Biology (M.L.H.V., A.v.E., E.v.d.S., E.W., A.H.S.) and Clinical Chemistry (O.v.T.), The Netherlands Cancer Institute, Amsterdam, The Netherlands; and Department of Pharmacology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey (Z.P.)
- Address correspondence to:
Dr. Alfred H. Schinkel, Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. E-mail: a.schinkel{at}nki.nl
A preliminary version of this study was previously presented as follows: Vlaming M (2009) ABC Transporter Compound Knockout Mice: Physiological and Pharmacological Characterization. Ph.D. thesis, University of Amsterdam, Amsterdam, The Netherlands.
Statistics from Altmetric.com
Article usage
In this issue
Impact of Abcc2 [Multidrug Resistance-Associated Protein (Mrp) 2], Abcc3 (Mrp3), and Abcg2 (Breast Cancer Resistance Protein) on the Oral Pharmacokinetics of Methotrexate and Its Main Metabolite 7-Hydroxymethotrexate
